Thomas T. Togioka, Md, Inc. Clinic/Center Medicare: Not Enrolled in Medicare Practice Location: 390 N Sepulveda Blvd, #1055, El Segundo, CA 90245 Phone: 310-673-3945 |
Torrance Health Association Internal Medicine Medicare: Medicare Enrolled Practice Location: 2110 E. El Segundo Blvd, Suite 100, El Segundo, CA 90245 Phone: 310-517-7010 |
Pacific Harbor Medical Group,inc Family Medicine Medicare: Medicare Enrolled Practice Location: 360 N Pacific Coast Hwy Ste 3000, El Segundo, CA 90245 Phone: 310-642-0100 Fax: 310-642-0546 |
Hydra Health Centers Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 400 Continental Blvd, Ste 600, El Segundo, CA 90245 Phone: 818-749-4778 |
El Segundo Medical Center Inc. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 455 Main St, El Segundo, CA 90245 Phone: 310-322-1611 Fax: 310-322-4589 |
Westside Medical Evaluators Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 400 Continental Blvd, Ste 600, El Segundo, CA 90245 Phone: 310-919-6811 Fax: 310-356-3203 |
Westchester Medical Group Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 360 N Sepulveda Blvd, Suite 3000, El Segundo, CA 90245 Phone: 310-670-1120 |
Mellman Mediccal Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 390 Ca-1 #1065, El Segundo, CA 90245 Phone: 310-643-7494 |
American Current Care Of California, A Medical Corporation Clinic/Center Medicare: Not Enrolled in Medicare Practice Location: 390 N Pacific Coast Hwy Ste 1000, El Segundo, CA 90245 Phone: 310-640-9911 Fax: 310-322-8068 |
El Segundo Medical Center Inc Clinic/Center Medicare: Medicare Enrolled Practice Location: 455 Main Street, El Segundo, CA 90245 Phone: 310-322-1611 Fax: 310-322-4589 |
News Archive
Exosome Diagnostics, a leading developer of biofluid-based molecular diagnostics for use in personalized medicine, today announced that the company is presenting a late-breaking abstract at the AACR Annual Meeting 2013, in Washington D.C.
The New York Times examines how "teams of veterinarians and conservation biologists are in the midst of a global effort with medical doctors and epidemiologists to understand the 'ecology of disease.'"
Pharmaxis has announced it had received notification from the United States Food and Drug Administration (FDA) that the New Drug Application (NDA) for its mannitol bronchial challenge test Aridol has been accepted for standard review. The FDA will advise the result of the review on 27 December 2009.
Researchers have identified a gene mutation that causes developmental delay, intellectual disability, behavioral abnormalities and musculoskeletal problems in children. The newly diagnosed condition, called NKAP-related syndrome, arises from mutations in the NKAP gene, which plays a key role in human development.
CONNECT(R), one of the nation's most successful organizations dedicated to creating and sustaining the growth of innovative technology and life science businesses, announced SynergEyes, Inc., the high Dk hybrid contact lens manufacturer, as the winner of its 22nd annual Most Innovative New Product (MIP) Award for 2009.
› Verified 7 days ago